L

LEXEO Therapeutics

48 employees

LEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Life Science

Date founded

2018

Funding rounds raised

Total raised

$100M

from 15 investors over 15 rounds

L

LEXEO Therapeutics raised undisclosed on August 28, 2023

Investors: Sarepta Therapeutics

L

LEXEO Therapeutics raised $100M on September 9, 2021

Investors: Laurion Capital Management LP, Gray's Creek Capital Partners, Lundbeckfonden / Lundbeck Foundation, Omega Funds, Longitude Capital, Intus Capital, Woodline Partners LP and PBM Capital Group

L

LEXEO Therapeutics raised $85M on January 7, 2021

Investors: Lundbeckfonden / Lundbeck Foundation, Omega Funds, Woodline Partners LP, The Invus Group, PBM Capital Group and Longitude Capital

FAQ